Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Review
DOI: 10.54448/ijn23231
Submitted: 07-03-2023
Published: 07-03-2023

Major roles of the gut microbiota and microRNAs in cardiovascular disease events: a systematic review

Costa Rica Hospital Foundation- Vitale Clinic, Costa Rica, MS, Brazil
Costa Rica Hospital Foundation- Vitale Clinic, Costa Rica, MS, Brazil
Gut microbiota Cardiovascular diseases microRNAs Nutrology

Abstract

Introduction: Gut microbiota (GM) is an essential mediator in the health of GM and has been identified as the origin of several diseases by influencing cell signaling and T cell receptor pathways in the central nervous system. Several microRNAs participate in signaling networks through GM intervention. The interaction between GM and miRNAs plays a crucial role in vascular dysfunction. GM can metabolize L-carnitine, choline, and phosphatidylcholine and produce vascular-toxic metabolites such as trimethylamine-Noxide (TMAO), which is associated with the atherosclerotic process. Nutrology and dietary therapy represent important strategies, especially with the use of plant-derived miRNAs to modify GM. Objective: To carry out a systematic review to highlight the main roles of the gut microbiota and microRNAs in cardiovascular disease events. Methods: The present study followed a concise systematic review model (PRISMA). The literary search process was carried out from March to May 2023 and was developed based on Scopus, PubMed, Science Direct, Scielo, and Google Scholar, using scientific articles from 2002 to 2022. The low quality of evidence was attributed to reports of cases, editorials, and brief communications, according to the GRADE instrument. The risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: The total of 126 studies were found for eligibility analysis, and then 42 of the 64 total studies were selected for this systematic review. According to the GRADE instrument, most studies showed homogeneity in their results, with X2 =88.7%>50%. It was concluded that the gut microbiota can be influenced by diet, genetics, and environmental factors. Changes in the microbial population can lead to multiple diseases, including cardiovascular disease. miRNAs have been known as important regulators of several biological functions, and are also involved in the pathogenesis of cardiovascular diseases. There is evidence that disturbances in the gut microbiota and derived metabolites impair the development of atherosclerotic cardiovascular disease. Studies have shown that YRNAs belonging to extracellular vesicles and their fragments play important roles in the initiation, progression, and diagnosis of atherosclerosis.

Metrics

Metrics Loading ...

References

  1. Feng Q, Chen WD, Wang YD. Gut Microbiota: An Integral Moderator in Health and Disease. Front Microbiol. 2018 Feb 21;9:151. doi: 10.3389/fmicb.2018.00151.
  2. Mody D, Verma V, Rani V. Modulating host gene expression via gut microbiomemicroRNA interplay to treat human diseases. Crit Rev Microbiol. 2021 Sep;47(5):596-611. doi: 10.1080/1040841X.2021.1907739.
  3. Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 2017, 13:e1006654. 10.1371/journal.ppat.1006654.
  4. Shukla SD, Budden KF, Neal R, Hansbro PM. Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology. 2017, 6:e133. 10.1038/cti.2017.6.
  5. Van de Wiele T, Van Praet JT, Marzorati M, Drennan MB, Elewaut D. How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol. 2016, 12:398–411. 10.1038/nrrheum.2016.85.
  6. Lynch JB, Hsiao EY. Microbiomes as sources of emergent host phenotypes. Science. 2019, 365:1405–9. 10.1126/science.aay0240.
  7. Chang CS, Kao CY. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci. 2019, 26:59. 10.1186/s12929-019-0554-5.
  8. Qin Y, Wade PA. Crosstalk between the microbiome and epigenome: messages from bugs. J Biochem. 2018, 163:105–12. 10.1093/jb/mvx080.
  9. Li M, Chen WD, Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol Med. 2020 26:101. 10.1186/s10020-020-00234-7.
  10. Ionescu RF, Boroghina SC, Cretoiu SM. Is there a link between the gut microbiome and arterial hypertension? J Hypertens Res. 2021, 7:12–7. Available online at: http://www.hypertens.org/images/202103/jhr-202103070103.pdf [Google Scholar].
  11. Cretoiu D, Ionescu RF, Enache RM, Cretoiu SM, Voinea SC. Gut microbiome, functional food, atherosclerosis, and vascular calcifications-is there a missing link? Microorganisms. 2021, 9:1913. 10.3390/microorganisms9091913.
  12. Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, et al.. TrimethylamineN-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018, 17:286. 10.1186/s12944-018-0939-6.
  13. Komaroff AL. The microbiome and risk for atherosclerosis. JAMA. 2018, 319:2381. 10.1001/jama.2018.5240.
  14. Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019, 7:e7502. 10.7717/peerj.7502.
  15. Behrouzi A, Ashrafian F, Mazaheri H, Lari A, Nouri M, Rad FR, et al.. The importance of interaction between MicroRNAs and gut microbiota in several pathways. Microb Pathog. 2020, 144:104200. 10.1016/j.micpath.2020.104200.
  16. Spinler JK, Karri V, Hirschi KD. Planting the microbiome. Trends Microbiol. 2019, 27:90–3. 10.1016/j.tim.2018.12.001.
  17. Zhao L, Zhou X, Cai W, Shi R, Yang G, Yuan L. Host intestinal epithelium derived MIRNAS shape the microbiota and its implication in cardiovascular diseases. J Am Coll Cardiol. 2017, 69:1075. 10.1016/S0735-1097(17)34464-9.
  18. Ding S, Liu G, Jiang H, Fang J. MicroRNA determines the fate of intestinal epithelial cell differentiation and regulates intestinal diseases. Curr Protein Pept Sci. 2019, 20:666–73. 10.2174/1389203720666190125110626.
  19. Watson AJM, Hall LJ. Regulation of host gene expression by gut microbiota. Gastroenterology. 2013, 144:841–4. 10.1053/j.gastro.2013.02.028.
  20. Sarshar M, Scribano D, Ambrosi C, Palamara AT, Masotti A. Fecal microRNAs as innovative biomarkers of intestinal diseases and effective players in hostmicrobiome interactions. Cancers. 2020, 12:2174. 10.3390/cancers12082174.
  21. Gaspar BS, Ionescu RF, Enache RM, Dobrica EC, Cretoiu SM, Cretoiu D, et al.. Extracellular Vesicles as Intercellular Communication Vehicles in Regenerative Medicine. Available online at: https://www.intechopen.com/onlinefirst/79775 (accessed april 10, 2023).
  22. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al.. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997–1006. 10.1038/cr.2008.282.
  23. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012, 110:483–95. 10.1161/CIRCRESAHA.111.247452.
  24. Genecards.org (2022). Available online at: https://www.genecards.org/cgibin/carddisp.pl?gene=MIR10B (accessed march 16, 2023).
  25. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004, 109:III27–32. 10.1161/01.CIR.0000131515.03336.f8.
  26. Wang D, Xia M, Yan X, Li D, Wang L, Xu Y, et al.. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res. 2012, 111:967–81. 10.1161/CIRCRESAHA.112.266502.
  27. Bodogai M, O'Connell J, Kim K, Kim Y, Moritoh K, Chen C, et al.. Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells. Sci Transl Med. 2018, 10:eaat4271. 10.1126/scitranslmed.aat4271.
  28. Zhao Y, Zeng Y, Zeng D, Wang H, Zhou M, Sun N, et al.. Probiotics and microRNA: their roles in the host-microbe interactions. Front Microbiol. 2020, 11:604462. 10.3389/fmicb.2020.604462.
  29. Nagai M, Obata Y, Takahashi D, Hase K. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis. Int Immunopharmacol. 2016, 37:79–86. 10.1016/j.intimp.2016.04.001.
  30. Wang J, Wang P, Li D, Hu X, Chen F. Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice. Eur J Nutr. 2020, 59:699–718. 10.1007/s00394-019-01938-1.
  31. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al.. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic: expert consensus document. Nat Rev Gastroenterol Hepatol. 2014, 11:506–14. 10.1038/nrgastro.2014.66.
  32. Ionescu RF, Enache RM, Cretoiu SM, Cretoiu D. The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases. Front Cardiovasc Med. 2022 Mar 16;9:856901. doi: 10.3389/fcvm.2022.856901.
  33. Romaine SPR, Tomaszewski M, Condorelli G, Samani NJ. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart. 2015, 101:921–8. 10.1136/heartjnl-2013-305402.
  34. Ionescu RF, Cretoiu SM. MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy. J Med Life. 2021, 14:142–7. 10.25122/jml2021-0071.
  35. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002, 12:735–9. 10.1016/S0960-9822(02)00809-6.
  36. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al.. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res. 2007, 100:1579–88. 10.1161/CIRCRESAHA.106.141986.
  37. Luo X, Zhang H, Xiao J, Wang Z. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem. 2010, 25:571–86. 10.1159/000315076.
  38. Wang Z, Lu Y, Yang B. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc Res. 2011, 89:710–21. 10.1093/cvr/cvq350.
  39. Xue H, Chen X, Yu C, Deng Y, Zhang Y, Chen S, Chen X, Chen K, Yang Y, Ling W. Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease. Circ Res. 2022 Aug 19;131(5):404-420. doi: 10.1161/CIRCRESAHA.122.321253.
  40. Tuttolomondo A, Simonetta I, Daidone M, Mogavero A, Ortello A, Pinto A. Metabolic and Vascular Effect of the Mediterranean Diet. Int J Mol Sci. 2019 Sep 23;20(19):4716. doi: 10.3390/ijms20194716.
  41. Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X. New insights into oxidative stress and inflammation during diabetes mellitusaccelerated atherosclerosis. Redox Biol. 2019 Jan;20:247-260. doi: 10.1016/j.redox.2018.09.025.
  42. Chen W, Li L, Wang J, Li Q, Zhang R, Wang S, Wu Y, Xing D. Extracellular vesicle YRNA in atherosclerosis. Clin Chim Acta. 2021 Jun;517:15-22. doi: 10.1016/j.cca.2021.02.003.

How to Cite

Assumpção, V. P. F., & Assumpção, O. Q. (2023). Major roles of the gut microbiota and microRNAs in cardiovascular disease events: a systematic review. International Journal of Nutrology, 16(2). https://doi.org/10.54448/ijn23231